BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 476715)

  • 1. Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm.
    Oster MW
    Cancer Treat Rep; 1979 Aug; 63(8):1417-8. PubMed ID: 476715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 3. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens.
    Woods RL; Fox RM; Tattersall MH; Levi JA; Brodie GN
    N Engl J Med; 1980 Jul; 303(2):87-9. PubMed ID: 6991941
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 7. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF; Weltz MD; Heim WJ; Blom J
    Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)].
    Israël L; Breau JL; Depierre A; Choffel C; Lemarié E; Battesti JP
    Rev Fr Mal Respir; 1981; 9(2):123-31. PubMed ID: 6166970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI; Bychkov MB; Ausekar BV
    Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for metastatic basal cell carcinoma.
    Coker DD; Elias EG; Viravathana T; McCrea E; Hafiz M
    Arch Dermatol; 1983 Jan; 119(1):44-50. PubMed ID: 6849564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
    Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
    Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
    Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
    Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
    Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M
    Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bone metastasis of breast cancer. Apropos of a series of 50 cases].
    Vincent-Joyeux F; Bontoux D; Alcalay M; Daban A; Vincent D
    Sem Hop; 1982 Dec; 58(48):2827-31. PubMed ID: 6302849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
    Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
    O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
    Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
    Pipino G; Germiniani R; Maione G; Fazio FM
    Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study on the treatment of pulmonary metastatic osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Nakasato T; Goto M; Ishii S; Sasaki T; Usui M; Yagi T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):998-1005. PubMed ID: 6964046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.